Details for Patent: 6,087,383
✉ Email this page to a colleague
Summary for Patent: 6,087,383
Title: | Bisulfate salt of HIV protease inhibitor |
Abstract: | The present invention provides the crystalline bisulfate salt of the formula ##STR1## which is found to have unexpectedly high solubility/dissolution rate and oral bioavailability relative to the free base form of this azapeptide HIV protease inhibitor compound. |
Inventor(s): | Singh; Janak (Lawrenceville, NJ), Pudipeddi; Madhusudhan (Plainsboro, NJ), Lindrud; Mark D. (Basking Ridge, NJ) |
Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
Application Number: | 09/217,538 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,087,383 |
Patent Claim Types: see list of patent claims | Compound; Composition; Dosage form; |
Drugs Protected by US Patent 6,087,383
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,087,383
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 014417 | ⤷ Sign Up | |||
Austria | 219057 | ⤷ Sign Up | |||
Australia | 2010199 | ⤷ Sign Up | |||
Australia | 735875 | ⤷ Sign Up | |||
Bulgaria | 104618 | ⤷ Sign Up | |||
Bulgaria | 64774 | ⤷ Sign Up | |||
Brazil | 9814736 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |